Malignant lymphomas/leukemias were found in PB-treated Ogg1−/− females (35%), and males (5%), and differences were significant in females (P < 0.05) as compared to control Ogg1−/− (0%) and PB-treated Ogg1+/+ (0%) mice. This evidence concerns the gene OGG1 and lymphoma.